Atallah Baydoun

Dr. Atallah Baydoun

orcid

Research Focus & Metrics

Academic Career Length

15Years (2012-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
9 June 2023 in Prostate Cancer and Prostatic Diseases
Verified
Journal Article
Closed access
PDF file
ABAtallah Baydoun
Atallah Baydoun
AJAngela Y. Jia
Angela Y. Jia
NZNicholas G. Zaorsky
Nicholas G. Zaorsky
RKRojano Kashani
Rojano Kashani
SRSantosh Rao
Santosh Rao
DSDaniel Spratt
Daniel Spratt

1 August 2018 in Artificial Intelligence in Medicine
Verified
Journal Article
Closed access
FLFan Liang
Fan Liang
PQPengjiang Qian
Pengjiang Qian
KSKuan-Hao Su
Kuan-Hao Su
ABAtallah Baydoun
Atallah Baydoun
ALAsha Leisser
Asha Leisser
RMRaymond F. Muzic
Raymond F. Muzic

6 August 2012 in Scandinavian Journal of Gastroenterology
Verified
Journal Article
Closed access
ABAtallah Baydoun
Atallah Baydoun
JMJoseph E. Maakaron
Joseph E. Maakaron
HHHoussam Halawi
Houssam Halawi
JRJihane Abou Rahal
Jihane Abou Rahal
Ali TaherAli Taher
Ali Taher
Celiac disease, an autoimmune disease once thought to be uncommon, is now being increasingly identified. Our improved diagnostic modalities have allowed us to diagnose more and more patients with atypical symptoms who improve on gluten-free diet (GFD). We discuss here the latest findings regarding the various hematological manifestations of celiac disease and their management. Anemia remains the most common hematological manifestation of celiac disease due to many mechanisms, and can be the sole presenting symptom. Other manifestations include thrombocytosis and thrombocythemia, leukopenia, thromboembolism, increased bleeding tendency, IgA deficiency, splenic dysfunction, and lymphoma. The diagnosis of celiac disease should always be kept in mind when a patient presents with unexplained and isolated hematological finding. Once diagnosed, patients should adhere to GFD and be educated about the potential complications of this disease. We herein present an algorithm for adequate management and follow-up.

11 December 2017 in Scientific Reports
Verified
Journal Article
Open access
PDF file
MBMartha Baydoun
Martha Baydoun
SVSadia Benamrouz Vanneste
Sadia Benamrouz Vanneste
CCColette Creusy
Colette Creusy
KGKarine Guyot
Karine Guyot
NGNausicaa Gantois
Nausicaa Gantois
GCGabriela Certad
Gabriela Certad
Cryptosporidium parvum is a major cause of diarrheal illness and was recently potentially associated with digestive carcinogenesis. Despite its impact on human health, Cryptosporidium pathogenesis remains poorly known, mainly due to the lack of a long-term culture method for this parasite. Thus, the aim of the present study was to develop a three-dimensional (3D) culture model from adult murine colon allowing biological investigations of the host-parasite interactions in an in vivo-like environment and, in particular, the development of parasite-induced neoplasia. Colonic explants were cultured and preserved ex vivo for 35 days and co-culturing was performed with C. parvum. Strikingly, the resulting system allowed the reproduction of neoplastic lesions in vitro at 27 days post-infection (PI), providing new evidence of the role of the parasite in the induction of carcinogenesis. This promising model could facilitate the study of host-pathogen interactions and the investigation of the process involved in Cryptosporidium-induced cell transformation.

8 January 2021 in IEEE Access
Verified
Journal Article
Open access
ABAtallah Baydoun
Atallah Baydoun
KXKe Xu
Ke Xu
JHJin Uk Heo
Jin Uk Heo
HYHuan Yang
Huan Yang
FZFeifei Zhou
Feifei Zhou
RMRaymond F. Muzic
Raymond F. Muzic
Multi-modality imaging constitutes a foundation of precision medicine, especially in oncology where reliable and rapid imaging techniques are needed in order to insure adequate diagnosis and treatment. In cervical cancer, precision oncology requires the acquisition of 18 F-labelled 2-fluoro-2-deoxy-D-glucose (FDG) positron emission tomography (PET), magnetic resonance (MR), and computed tomography (CT) images. Thereafter, images are co-registered to derive electron density attributes required for FDG-PET attenuation correction and radiation therapy planning. Nevertheless, this traditional approach is subject to MR-CT registration defects, expands treatment expenses, and increases the patient's radiation exposure. To overcome these disadvantages, we propose a new framework for cross-modality image synthesis which we apply on MR-CT image translation for cervical cancer diagnosis and treatment. The framework is based on a conditional generative adversarial network (cGAN) and illustrates a novel tactic that addresses, simplistically but efficiently, the paradigm of vanishing gradient vs. feature extraction in deep learning. Its contributions are summarized as follows: 1) The approach-termed sU-cGAN- uses, for the first time, a shallow U-Net (sU-Net) with an encoder/decoder depth of 2 as generator; 2) sU-cGAN's input is the same MR sequence that is used for radiological diagnosis, i.e. T2-weighted, Turbo Spin Echo Single Shot (TSE-SSH) MR images; 3) Despite limited training data and a single input channel approach, sU-cGAN outperforms other state of the art deep learning methods and enables accurate synthetic CT (sCT) generation. In conclusion, the suggested framework should be studied further in the clinical settings. Moreover, the sU-Net model is worth exploring in other computer vision tasks.

12 June 2019 in Medical Physics
Verified
Journal Article
Closed access
PDF file
KSKuan‐Hao Su
Kuan‐Hao Su
HFHarry T. Friel
Harry T. Friel
JKJung‐Wen Kuo
Jung‐Wen Kuo
RHRose Al Helo
Rose Al Helo
ABAtallah Baydoun
Atallah Baydoun
RMRaymond F. Muzic
Raymond F. Muzic